Biologically Active Small Molecules

A synthetic intermediate useful for pharmaceutical synthesis.

A specific inhibitor of PI3K activity and a widely used inhibitor of the autophagy at 5 mM, inhibits protein degradation in rat hepatocytes by 65% and blocks class I, II, and III PI3Ks, including some downstream targets.

A specific inhibitor of PI3K activity and a widely used inhibitor of the autophagy at 5 mM, inhibits protein degradation in rat hepatocytes by 65% and blocks class I, II, and III PI3Ks, including some downstream targets.

A specific inhibitor of PI3K activity and a widely used inhibitor of the autophagy at 5 mM, inhibits protein degradation in rat hepatocytes by 65% and blocks class I, II, and III PI3Ks, including some downstream targets.

An irreversible inhibitor of mitochondrial Complex II succinate dehydrogenase, resulting in energy depletion through disruption of the electron transport chain used in animal models of Huntington&rsquos disease and epilepsy.

An irreversible inhibitor of mitochondrial Complex II succinate dehydrogenase, resulting in energy depletion through disruption of the electron transport chain used in animal models of Huntington&rsquos disease and epilepsy.

An irreversible inhibitor of mitochondrial Complex II succinate dehydrogenase, resulting in energy depletion through disruption of the electron transport chain used in animal models of Huntington&rsquos disease and epilepsy.

Formal Name: 2-(acetylamino)-2-deoxy-3-O-methyl-D-glucose Synonyms: 3-OMe-GlcNAc Molecular Formula: C₉H₁₇NO₆ Formula Weight: 235.2

Formal Name: 2-(acetylamino)-2-deoxy-3-O-methyl-D-glucose Synonyms: 3-OMe-GlcNAc Molecular Formula: C₉H₁₇NO₆ Formula Weight: 235.2

Formal Name: 2-(acetylamino)-2-deoxy-3-O-methyl-D-glucose Synonyms: 3-OMe-GlcNAc Molecular Formula: C₉H₁₇NO₆ Formula Weight: 235.2

An intermediate in the dissociated (or type II) fatty acid biosynthesis that occurs in bacteria generated following the reaction of hexadecenoyl-ACP with malonyl-ACP by the enzyme &beta-ketoacyl-ACP synthase II (EC 2.3.

An intermediate in the dissociated (or type II) fatty acid biosynthesis that occurs in bacteria generated following the reaction of hexadecenoyl-ACP with malonyl-ACP by the enzyme &beta-ketoacyl-ACP synthase II (EC 2.3.